Gardasil royalties are about 20% of CSL's profit, and these are mooted to fall about 20%, and hence the negative impact is some 4%. The market has over reacted to the news that the USA licensee of Gardasil had lowered sales forecasts.
The foregoing arithmetic is a rough approximation, and 4% might be too high, but the thrust of what I write here is probably correct.
Pioupiou
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$240.92 |
Change
0.000(0.00%) |
Mkt cap ! $116.6B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | $243.59 | $239.87 | $4.346M | 18.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23 | $289.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $192.74 | 103 | 2 |
View Market Depth
| Last trade - 09.50am 14/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |